Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection-Reference-Cited by-同舟云学术

Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection

Published:2020-08-26 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Dinnes Jacqueline¹²,Deeks Jonathan J¹²,Adriano Ada¹,Berhane Sarah²,Davenport Clare¹²,Dittrich Sabine³,Emperador Devy³,Takwoingi Yemisi¹²,Cunningham Jane⁴,Beese Sophie¹,Dretzke Janine¹,Ferrante di Ruffano Lavinia¹,Harris Isobel M¹,Price Malcolm J¹,Taylor-Phillips Sian⁵,Hooft Lotty⁶,Leeflang Mariska MG⁷⁸,Spijker René⁶⁹,Van den Bruel Ann¹⁰,

Affiliation:

1. Test Evaluation Research Group, Institute of Applied Health Research; University of Birmingham; Birmingham UK

2. NIHR Birmingham Biomedical Research Centre; University Hospitals Birmingham NHS Foundation Trust and University of Birmingham; Birmingham UK

3. FIND; Geneva Switzerland

4. Global Malaria Programme; World Health Organization; Geneva Switzerland

5. Division of Health Sciences, Warwick Medical School; University of Warwick; Coventry UK

6. Cochrane Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University; Utrecht Netherlands

7. Department of Clinical Epidemiology, Biostatistics and Bioinformatics; Amsterdam University Medical Centers, University of Amsterdam; Amsterdam Netherlands

8. Biomarker and Test Evaluation Programme (BiTE); Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands

9. Medical Library; Amsterdam UMC, University of Amsterdam, Amsterdam Public Health; Amsterdam Netherlands

10. Department of Public Health and Primary Care; KU Leuven; Leuven Belgium

Publisher

Wiley

Subject

Pharmacology (medical)

Reference124 articles.

1. Performance evaluation of the point-of-care SAMBA II SARS-CoV-2 test for detection of SARS-CoV-2;Assennato;medRxiv [Preprint]

2. Test agreement between Roche cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 assays at high cycle threshold ranges;Broder;Journal of Clinical Microbiology,2020

3. Test agreement between Roche cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 assays at high cycle threshold ranges;Broder;bioRxiv [Preprint]

4. Diagnosis of acute respiratory syndrome coronavirus 2 infection by detection of nucleocapsid protein;Diao;medRxiv [Preprint]

5. Comparison of Abbott ID NOW and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients;Harrington;Journal of Clinical Microbiology,2020

Cited by 901 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 lateral flow test image classification using deep CNN and StyleGAN2;Frontiers in Artificial Intelligence;2024-01-29

2. A high throughput immuno-affinity mass spectrometry method for detection and quantitation of SARS-CoV-2 nucleoprotein in human saliva and its comparison with RT-PCR, RT-LAMP, and lateral flow rapid antigen test;Clinical Chemistry and Laboratory Medicine (CCLM);2024-01-23

3. Public health-focused use of COVID-19 rapid antigen and PCR tests;Scientific Reports;2024-01-16

4. Usage of Diagnosis and Screening Tests in New Coronavirus Disease (Covıd-19);Arşiv Kaynak Tarama Dergisi;2023-12-31

5. Number of initial symptoms of SARS-CoV-2 infection is associated with the risk of otological symptoms: a retrospective study;BMC Infectious Diseases;2023-12-07